image
Industrials - Consulting Services - NASDAQ - US
$ 74.86
-0.252 %
$ 3.8 B
Market Cap
36.86
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one EXPO stock under the worst case scenario is HIDDEN Compared to the current market price of 74.9 USD, Exponent, Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one EXPO stock under the base case scenario is HIDDEN Compared to the current market price of 74.9 USD, Exponent, Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one EXPO stock under the best case scenario is HIDDEN Compared to the current market price of 74.9 USD, Exponent, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart EXPO

image
$105.0$105.0$100.0$100.0$95.0$95.0$90.0$90.0$85.0$85.0$80.0$80.0$75.0$75.0$70.0$70.015 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
559 M REVENUE
4.05%
120 M OPERATING INCOME
7.40%
109 M NET INCOME
8.63%
145 M OPERATING CASH FLOW
13.49%
-6.94 M INVESTING CASH FLOW
57.58%
-65.1 M FINANCING CASH FLOW
24.30%
146 M REVENUE
6.39%
44.4 M OPERATING INCOME
63.04%
23.6 M NET INCOME
-9.43%
56.1 M OPERATING CASH FLOW
88.64%
-2.6 M INVESTING CASH FLOW
-51.52%
-12.3 M FINANCING CASH FLOW
4.93%
Balance Sheet Exponent, Inc.
image
Current Assets 447 M
Cash & Short-Term Investments 259 M
Receivables 161 M
Other Current Assets 26.6 M
Non-Current Assets 330 M
Long-Term Investments 0
PP&E 148 M
Other Non-Current Assets 182 M
33.31 %20.77 %3.42 %19.07 %23.43 %Total Assets$777.3m
Current Liabilities 163 M
Accounts Payable 5.27 M
Short-Term Debt 7.28 M
Other Current Liabilities 151 M
Non-Current Liabilities 193 M
Long-Term Debt 0
Other Non-Current Liabilities 193 M
42.29 %54.19 %Total Liabilities$356.2m
EFFICIENCY
Earnings Waterfall Exponent, Inc.
image
Revenue 559 M
Cost Of Revenue 416 M
Gross Profit 142 M
Operating Expenses 439 M
Operating Income 120 M
Other Expenses 10.6 M
Net Income 109 M
600m600m500m500m400m400m300m300m200m200m100m100m00(100m)(100m)(200m)(200m)(300m)(300m)559m(416m)142m(439m)120m(11m)109mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
25.48% GROSS MARGIN
25.48%
21.41% OPERATING MARGIN
21.41%
19.52% NET MARGIN
19.52%
25.89% ROE
25.89%
14.02% ROA
14.02%
14.23% ROIC
14.23%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Exponent, Inc.
image
140m140m120m120m100m100m80m80m60m60m40m40m20m20m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 109 M
Depreciation & Amortization 9.69 M
Capital Expenditures -6.94 M
Stock-Based Compensation 23.2 M
Change in Working Capital 1.46 M
Others 3.97 M
Free Cash Flow 138 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Exponent, Inc.
image
Wall Street analysts predict an average 1-year price target for EXPO of $104 , with forecasts ranging from a low of $88 to a high of $120 .
EXPO Lowest Price Target Wall Street Target
88 USD 17.55%
EXPO Average Price Target Wall Street Target
104 USD 38.93%
EXPO Highest Price Target Wall Street Target
120 USD 60.30%
Price
Max Price Target
Min Price Target
Average Price Target
120120115115110110105105100100959590908585808075757070Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.39% DIVIDEND YIELD
0.3 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.2001.2001.0001.0000.8000.8000.6000.6000.4000.4000.2000.2000.0000.0000.0750.090.1050.130.160.190.20.240.260.280.30.0750.090.1050.130.160.190.20.240.260.280.30.0750.090.1050.130.160.190.20.240.260.280.0750.300.090.360.1050.420.130.520.160.640.190.760.20.800.240.960.261.040.281.120.602015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 7
6. Ownership
Insider Ownership Exponent, Inc.
image
Sold
0-3 MONTHS
149 K USD 1
3-6 MONTHS
124 K USD 1
6-9 MONTHS
2.52 M USD 2
9-12 MONTHS
15.9 M USD 7
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Exponent, Inc. (EXPO) Q1 2025 Earnings Conference Call Transcript Exponent, Inc. (NASDAQ:EXPO ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Joni Konstantelos - MD, Riveron Consulting, IR Catherine Corrigan - President and CEO Rich Schlenker - EVP and CFO Conference Call Participants Jasper Bibb - Truist Andrew Nicholas - William Blair Josh Chan - UBS Operator Good day and welcome to the Exponent, Inc. First Quarter 2025 Earnings Conference Call. All participants will be in the listen-only mode. seekingalpha.com - 2 weeks ago
Exponent (EXPO) Q1 Earnings and Revenues Beat Estimates Exponent (EXPO) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.59 per share a year ago. zacks.com - 2 weeks ago
Exponent Reports First Quarter 2025 Financial Results MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2025 ended April 4, 2025. globenewswire.com - 2 weeks ago
Exponent Declares Regular Quarterly Dividend for Q2 2025 MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on June 20, 2025 to all common stockholders of record as of June 6, 2025. globenewswire.com - 2 weeks ago
Exponent to Announce First Quarter of Fiscal Year 2025 Results and Host Quarterly Conference Call on May 1, 2025 MENLO PARK, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report First Quarter of fiscal year 2025 financial results for the period ended April 4, 2025 following the close of the market on Thursday, May 1, 2025. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company's business and financial results. globenewswire.com - 1 month ago
Paysign, Inc. to Present at the Ladenburg Thalmann Technology Innovation EXPO25 HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Ladenburg Thalmann Technology Innovation EXPO25. businesswire.com - 1 month ago
Exponent: A Unique Dividend Contender That Is Valued At A Premium Exponent Inc. is a market leader in scientific and engineering consulting, with a 13-year dividend growth streak and a solid balance sheet. Despite strong revenue and earnings growth, the valuation is at a premium, making Exponent a hold. The company's competitive advantages include its reputation, technical expertise, and long-term client relationships, ensuring continued market leadership. seekingalpha.com - 2 months ago
31 Upcoming Dividend Increases, Including 3 Kings This week sees 31 dividend increases, including three Dividend Kings: Genuine Parts, Commerce Bancshares, and Kimberly-Clark, showcasing impressive financial stability and growth. My investment strategy prioritizes companies with consistently rising dividends and outperforming benchmarks, aiming for long-term wealth accumulation and portfolio prosperity. I use data from the "U.S. Dividend Champions" spreadsheet and NASDAQ to identify companies with at least five years of dividend growth. seekingalpha.com - 2 months ago
New Strong Sell Stocks for February 27th CAT, CABGY and EXPO have been added to the Zacks Rank #5 (Strong Sell) List on February 27, 2025. zacks.com - 2 months ago
Exponent, Inc. (EXPO) Q4 2024 Earnings Call Transcript Exponent, Inc. (NASDAQ:EXPO ) Q4 2024 Earnings Conference Call February 6, 2024 4:30 PM ET Company Participants Joni Konstantelos - MD, Riveron Consulting Catherine Corrigan - President and CEO Rich Schlenker - EVP and CFO Conference Call Participants Andrew Nicholas - William Blair Tobey Sommer - Truist Josh Chan - UBS Operator Good day, and welcome to the Exponent, Inc. Q4 2024 Earnings Conference Call. All participants will be in listen-only mode. seekingalpha.com - 3 months ago
Exponent (EXPO) Q4 Earnings and Revenues Top Estimates Exponent (EXPO) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.41 per share a year ago. zacks.com - 3 months ago
Baron Small Cap Fund: Q4 2024 Top Contributors And Detractors Vertiv Holdings Co. excels with strong AI-related data center demand, projecting 16%-18% organic revenue growth for 2025, and increased profit margins. Chart Industries, Inc. shows robust fundamentals with record revenue and margins, expecting 12% revenue and 18% EBITDA growth in 2025. Intapp, Inc. benefits from strong quarterly results, 17% revenue growth, and a record pipeline, driven by AI product demand and favorable M&A activity. seekingalpha.com - 3 months ago
8. Profile Summary

Exponent, Inc. EXPO

image
COUNTRY US
INDUSTRY Consulting Services
MARKET CAP $ 3.8 B
Dividend Yield 0.39%
Description Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Contact 149 Commonwealth Drive, Menlo Park, CA, 94025 https://www.exponent.com
IPO Date Aug. 17, 1990
Employees 1168
Officers Dr. Catherine Ford Corrigan P.E., Ph.D. President, Chief Executive Officer & Director Dr. Maureen T. F. Reitman F.S.P.E., P.E., Sc.D. Group Vice President Mr. Brian Kundert Chief Human Resources Officer Mr. Richard L. Schlenker Jr. Executive Vice President, Chief Financial Officer & Corporate Secretary Ms. Gina Flynn Vice President of Legal & General Counsel Dr. Joseph Rakow Ph.D. Group Vice President Dr. Joseph Sala Ph.D. Group Vice President Dr. Bernard Ross P.E., Ph.D. Co-Founder, Chairman Emeritus & Principal Engineer Mr. Eric R. Anderson Vice President of Finance & Accounting Dr. Subbaiah V. Malladi P.E., Ph.D. Chief Technology Officer & Principal Engineer